| Name | Palazestrant |
|---|
| Description | Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant in combination with a HER2 inhibitor, works on ER+/HER2+ cancer[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C28H36FN3O |
|---|---|
| Molecular Weight | 449.60 |